ACAMPA, MAURIZIO
 Distribuzione geografica
Continente #
EU - Europa 5.971
NA - Nord America 5.164
AS - Asia 1.001
AF - Africa 57
OC - Oceania 18
SA - Sud America 18
Continente sconosciuto - Info sul continente non disponibili 8
AN - Antartide 1
Totale 12.238
Nazione #
US - Stati Uniti d'America 5.137
GB - Regno Unito 1.290
IE - Irlanda 1.032
IT - Italia 880
DE - Germania 713
CN - Cina 580
SE - Svezia 580
RU - Federazione Russa 528
UA - Ucraina 364
FR - Francia 259
SG - Singapore 211
FI - Finlandia 152
VN - Vietnam 91
CI - Costa d'Avorio 48
ES - Italia 38
IN - India 30
BE - Belgio 29
CZ - Repubblica Ceca 24
NL - Olanda 22
GR - Grecia 21
CA - Canada 17
TR - Turchia 17
AU - Australia 16
IR - Iran 16
BR - Brasile 7
CH - Svizzera 7
EU - Europa 7
AE - Emirati Arabi Uniti 6
CL - Cile 6
IL - Israele 6
AT - Austria 4
BD - Bangladesh 4
JP - Giappone 4
KG - Kirghizistan 4
PH - Filippine 4
PK - Pakistan 4
RO - Romania 4
EE - Estonia 3
EG - Egitto 3
ID - Indonesia 3
KR - Corea 3
MA - Marocco 3
MY - Malesia 3
TH - Thailandia 3
AR - Argentina 2
AZ - Azerbaigian 2
BB - Barbados 2
BY - Bielorussia 2
HK - Hong Kong 2
HR - Croazia 2
MX - Messico 2
NG - Nigeria 2
NZ - Nuova Zelanda 2
PA - Panama 2
PE - Perù 2
PL - Polonia 2
SI - Slovenia 2
SK - Slovacchia (Repubblica Slovacca) 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
BG - Bulgaria 1
CR - Costa Rica 1
CY - Cipro 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
GD - Grenada 1
GS - Georgia del Sud e Isole Sandwich Australi 1
IQ - Iraq 1
IS - Islanda 1
JM - Giamaica 1
KE - Kenya 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
LT - Lituania 1
LU - Lussemburgo 1
LV - Lettonia 1
MD - Moldavia 1
NO - Norvegia 1
OM - Oman 1
PT - Portogallo 1
RS - Serbia 1
SA - Arabia Saudita 1
TM - Turkmenistan 1
VE - Venezuela 1
Totale 12.238
Città #
Southend 1.165
Dublin 999
Fairfield 800
Chandler 478
Ashburn 420
Woodbridge 335
Wilmington 294
Siena 288
Jacksonville 287
Seattle 281
Cambridge 274
Houston 267
Ann Arbor 234
Princeton 178
Menlo Park 173
Beijing 154
Singapore 153
Nanjing 108
Dong Ket 90
Helsinki 88
Boardman 84
Dearborn 82
Vimercate 78
New York 72
Florence 70
Moscow 64
San Diego 62
Shanghai 49
Abidjan 48
Nanchang 46
San Mateo 42
Milan 36
Málaga 33
Mestre 30
Munich 30
Pisa 29
London 28
Brussels 27
Rome 25
Shenyang 25
Chicago 20
Jiaxing 20
Brno 18
Lancaster 18
Tianjin 18
Changsha 17
Livorno 17
Paris 17
Lappeenranta 16
San Francisco 16
Washington 16
Jinan 15
Los Angeles 15
Prato 15
Toronto 15
Kunming 14
Hebei 13
Norwalk 13
Frankfurt am Main 12
Guangzhou 12
Dallas 11
Hangzhou 11
Izmir 11
Pune 11
Arezzo 10
Columbus 10
Fremont 10
Ningbo 9
Perugia 8
Taizhou 8
Zanjan 8
Melbourne 7
Nicola 7
Vicopisano 7
Zhengzhou 7
Düsseldorf 6
Hefei 6
Hounslow 6
Hyderabad 6
Queens 6
Sinalunga 6
São Paulo 6
Amsterdam 5
Bologna 5
Bonndorf 5
Campi Bisenzio 5
Casalzuigno 5
Kilburn 5
Petah Tikva 5
Sacramento 5
Santiago 5
Sydney 5
Bishkek 4
Caserta 4
Clifton 4
Edinburgh 4
Falls Church 4
Leawood 4
Olomouc 4
Phoenix 4
Totale 8.602
Nome #
Marked QTc Prolongation and Torsades de pointes in Patients with Chronic Inflammatory Arthritis 250
Arrhythmogenicity of Anti-Ro/SSA antibodies in patients with torsades de pointes 237
Proton pump inhibitors and serum magnesium levels in patients with Torsades de Pointes 232
P wave dispersion in cryptogenic stroke: A risk factor for cardioembolism? 230
Association between high sensitivity C-reactive protein, heart rate variability and corrected QT interval in patients with chronic inflammatory arthritis. 220
Antiarrhythmic potential of anti-cytokine therapy in rheumatoid arthritis: Tocilizumab reduces QTc interval by controlling systemic inflammation. 213
Systemic thrombolysis for stroke in pregnancy 207
Torsades de Pointes in patients with polymyalgia rheumatica 201
Spotlight on sirukumab for the treatment of rheumatoid arthritis: The evidence to date 193
Autonomic activity and baroreflex sensitivity in patients submitted to carotid stenting 192
Predictors of long-term recovery in complex activities of daily living before discharge from the stroke unit 180
Time Course of Corticospinal Excitability and Autonomic Function Interplay during and Following Monopolar tDCS 180
Systemic Inflammation Rapidly Induces Reversible Atrial Electrical Remodeling: The Role of Interleukin-6–Mediated Changes in Connexin Expression 180
Anti-Ro/SSA-associated corrected QT interval prolongation in adults: the role of antibody level and specificity 176
Endovascular treatment of early recurrent ischemic stroke following intravenous thrombolysis 176
Delineation of the phenotype associated with 7q36.1q36.2 deletion: long QT syndrome, renal hypoplasia and mental retardation 167
Thrombolytic treatment of cardiac myxoma-induced ischemic stroke: a review 161
Stroke warning syndrome: 18 new cases 161
Connective tissue diseases and cardiac rhythm disorders: an overview 160
Double ophthalmic arteries arising from the internal carotid artery. A case report of a hidden second ophthalmic artery 158
Genetic influence in antithrombotic actions of atorvastatin in hypercholesterolaemia 157
How to Identify Patients at Risk of Silent Atrial Fibrillation after Cryptogenic Stroke: Potential Role of P Wave Dispersion 156
Microvascular abnormalities in Rett Syndrome 156
Comparison of frequency of complex ventricular arrhythmias in patients with positive versus negative anti-Ro/SSA and connective tissue disease 155
Increased arterial stiffness is an independent risk factor for hemorrhagic transformation in ischemic stroke undergoing thrombolysis 155
Prolongation of the corrected QT interval in adult patients with anti-Ro/SSA positive connective tissue diseases 154
Safety of intravenous thrombolysis in ischemic stroke caused by left atrial myxoma 153
Cardiac dysautonomia and serotonin plasma levels in Rett syndrome 150
Neuroimaging and definition of transient ischemic attack 150
Early and delayed increase in plasma homocysteine levels in heart transplanted patients. 149
Previous use of statins and atrial electrical remodeling in patients with cryptogenic stroke 147
Pravastatin treatment-associated reduction in plasma homocysteine in heart-transplanted patients. 145
Prediction of Early Recurrent Thromboembolic Event and Major Bleeding in Patients With Acute Stroke and Atrial Fibrillation by a Risk Stratification Schema: The ALESSA Score Study 145
Cardiac autonomic nervous system and risk of arrhythmias in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL). 144
Cardiac dysautonomia and arterial distensibility in essential hypertensives 142
Autoantibody-mediated cardiac arrhythmias: mechanisms and clinical implications 141
null 141
Arrhythmic risk in rheumatoid arthritis: the driving role of systemic inflammation. 141
Relationship between the modified Rankin Scale and the Barthel Index in the process of functional recovery after stroke 139
Inflammatory cytokines, life-threatening arrhythmias and premature mortality in chronic inflammatory arthritis: Time to focus on 139
Autonomic dysfunction in mental retardation and spastic paraparesis with MECP2 mutation. 135
Sympathetic overactivity and plasma leptin levels in Rett syndrome 134
Acute effects of glibenclamide on reactive hyperaemia in the lower limbs in humans. 133
Androgen Deprivation Therapy for Prostatic Cancer in Patients With Torsades de Pointes 131
Cardiac dysautonomia in patients with superior vena cava syndrome due to compression by lung cancer. 129
Electromagnetic fields produced by incubators influence heart rate variability in newborns 128
Atrial cardiopathy and sympatho-vagal imbalance in cryptogenic stroke: Pathogenic mechanisms and effects on electrocardiographic markers 126
null 124
Cardiac arrest risk during acute infections: systemic inflammation directly prolongs QTc interval via cytokine-mediated effects on potassium channel expression 124
Proton pump inhibitors directly block hERG-potassium channel and independently increase the risk of QTc prolongation in a large cohort of US Veterans 124
Pharmacogenetics of statins therapy 123
null 122
Aortic stiffness in patients with deep and lobar intracerebral hemorrhage: role of antihypertensive drugs and statins: response to letter 122
Sudden death and cardiac arrhythmias in Rett syndrome 118
Corrected QT interval in anti-SSA-positive adults with connective tissue disease: Comment on the article by Lazzerini et al. [6] (multiple letters) 117
Arrhythmic risk during acute infusion of infliximab: a prospective, single-blind, placebo-controlled, cross-over study in patients with chronic arthritis 115
Oral low-dose dipyridamole protects from intravenous high-dose dipyridamole-induced ischemia. A oral echocardiographic study 113
Nerve growth factor plasma levels and ventricular repolarization in Rett syndrome 112
Arrhythmogenic effects of anti-Ro/SSA antibodies on theadult heart: more than expected? 110
Cranial osteolytic metastases as the only recurrence of gastric carcinoma 108
Effects of acetyl-L-carnitine on cardiac dysautonomia in Rett syndrome: prevention of sudden death? 107
Anticoagulation after Stroke in Patients with Atrial Fibrillation: To Bridge or Not with Low-Molecular-Weight Heparin? 105
Homocysteine and P wave dispersion in patients with heart transplantation 104
P wave dispersion and silent atrial fibrillation in cryptogenic stroke: The pathogenic role of inflammation 102
Anti-Ro/SSA Antibodies Blocking Calcium Channels as a Potentially Reversible Cause of Atrioventricular Block in Adults 100
Bosentan treatment on Raynaud Phenomenon and Skin Fibrosis in Patients with Systemic Sclerosis and with Pulmonary Arterial Hypertension: an open-label, observational, retrospective study 99
Effects of acute administration of iloprost on the cardiac autonomic nervous system and ventricular repolarisation in patients with systemic sclerosis 93
Hemorrhagic transformation in patients with acute ischemic stroke and atrial fibrillation: Time to initiation of oral anticoagulant therapy and outcomes 84
Electrocardiographic Predictors of Silent Atrial Fibrillation in Cryptogenic Stroke 81
Early recurrence and major bleeding in patients with acute ischemic stroke and atrial fibrillation treated with Non-Vitamin-K oral anticoagulants (RAF-NOACs) Study 77
Risk of qtc interval prolongation associated with circulating anti-ro/ssa antibodies among us veterans: an observational cohort study 76
Transient hypogonadism is associated with heart rate-corrected QT prolongation and torsades de pointes risk during active systemic inflammation in men 72
Safety of anticoagulation in patients treated with urgent reperfusion for ischemic stroke related to atrial fibrillation 70
Increased Arterial Stiffness is a Predictor of Delayed Ischaemic Stroke After Subarachnoid Haemorrhage 67
Acute ischemic stroke and concomitant massive pulmonary embolism: a challenge 67
Increased arterial stiffness is associated with poor collaterals in acute ischemic stroke from large vessel occlusion 66
Causes and Risk Factors of Cerebral Ischemic Events in Patients with Atrial Fibrillation Treated with Non-Vitamin K Antagonist Oral Anticoagulants for Stroke Prevention: The RENo Study 65
null 65
Early recurrence in paroxysmal versus sustained atrial fibrillation in patients with acute ischaemic stroke 64
Practical "1-2-3-4-Day" Rule for Starting Direct Oral Anticoagulants After Ischemic Stroke With Atrial Fibrillation: Combined Hospital-Based Cohort Study 64
Timing of initiation of oral anticoagulants in patients with acute ischemic stroke and atrial fibrillation comparing posterior and anterior circulation strokes 62
null 61
Letter regarding “Combined aspiration thrombectomy and continuous intrasinus thrombolysis for cerebral venous sinus thrombosis: technical note and case series” 59
Interleukin-6 elevation Is a key pathogenic factor underlying COVID-19-associated heart rate-corrected QT interval prolongation 57
Cardiac disease and Rett syndrome 57
Inflammation and Atrial Electrical Remodelling in Patients With Embolic Strokes of Undetermined Source 57
Autonomic nervous system alterations in Rett syndrome 54
Single-center experience using the 3MAX or 4MAX reperfusion catheter for the treatment of acute ischemic stroke with distal arterial occlusions in patients not eligible for intravenous fibrinolysis 53
Non-stenosing carotid atherosclerosis and arterial stiffness in embolic stroke of undetermined source 50
Outcome after acute ischemic stroke treatment during Covid-19 outbreak in South-East Tuscany 50
Perioperative stroke and hyperhomocysteinemia: A possible pathogenic link 46
To the Editor— Anticoagulation in atrial fibrillation after intracranial hemorrhage: Could the hemorrhage location influence the outcome? 44
Reduced heart rate variability in patients affected with Rett syndrome. A possible explanation for sudden death 43
Oral anticoagulants in the oldest old with recent stroke and atrial fibrillation 43
Letter by Acampa et al Regarding Article, "Delayed Cerebral Ischemia After Aneurysmal Subarachnoid Hemorrhage in Patients With a History of Migraine" 42
Elevated Interleukin-6 Levels Are Associated With an Increased Risk of QTc Interval Prolongation in a Large Cohort of US Veterans 42
Maternal Anti-Ro/SSA Autoantibodies and Prolonged PR Interval in a Competitive Athlete: Beyond Training-Induced Electrical Remodeling 39
Risk factors for intracerebral hemorrhage in patients with atrial fibrillation on Non-Vitamin K antagonist oral anticoagulants for stroke prevention 38
Markers of atrial cardiopathy in severe embolic strokes of undetermined source 36
Advanced Atrioventricular Block in Athletes: Prevalence and Role of Anti-Ro/Sjögren Syndrome-Related Antigen A Antibodies 36
Totale 11.878
Categoria #
all - tutte 46.221
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 46.221


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.364 0 0 0 0 105 252 212 254 164 197 65 115
2020/20211.786 98 156 78 194 78 170 113 202 255 136 154 152
2021/20221.561 114 157 54 130 78 27 56 154 123 128 226 314
2022/20231.837 114 218 247 233 148 339 72 130 150 60 85 41
2023/20242.013 62 27 158 111 87 499 558 47 34 51 118 261
2024/20251.045 105 185 351 319 85 0 0 0 0 0 0 0
Totale 12.595